ImmunityBio

IBRX

Börsenwert 8,58 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Wildcat Capital Management New York	37 Mio. $	–	–	–
2	2 Callan Capital La Jolla, California	30,9 Mio. $	+363.524 $	+38.573	+1 %
3	3 Capital Research Global Investors Los Angeles, California	21,9 Mio. $	–	–	–
4	4 Fidelity Investments Boston, Massachusetts	19,1 Mio. $	-1,54 Mio. $	-163.400	-7 %
5	5 Franklin Resources San Mateo, California	14,5 Mio. $	-46.368 $	-4.920	-0,3 %
6	6 Vanguard Group Malvern, Pennsylvania	11,4 Mio. $	+6,17 Mio. $	+654.682	+89 %
7	7 BlackRock Fund Advisors San Francisco, California	10,1 Mio. $	+1,09 Mio. $	+115.958	+10 %
8	8 RS Investment Management San Francisco, California	9,15 Mio. $	+764.282 $	+81.097	+8 %
9	9 Bank of America Charlotte, North Carolina	2,94 Mio. $	-50.910 $	-5.402	-1 %
10	AG 10 Artal Group Luxembourg	1,85 Mio. $	–	–	–
11	11 Avoro Capital Advisors New York	1,6 Mio. $	-3,81 Mio. $	-404.375	-67 %
12	12 BlackRock Institutional Trust San Francisco, California	1,54 Mio. $	-15.710 $	-1.667	-0,9 %
13	13 Massachusetts Financial Services Boston, Massachusetts	1,51 Mio. $	+21.883 $	+2.322	+1 %
14	14 JP Morgan Chase New York	1,25 Mio. $	+31.185 $	+3.309	+2 %
15	15 State Street Boston, Massachusetts	1,02 Mio. $	+221.443 $	+23.497	+23 %
16	16 Deutsche Bank Frankfurt Am Main Ge, Germany	807.000 $	-336.636 $	-35.720	-27 %
17	17 Goldman Sachs New York	755.000 $	-1,29 Mio. $	-136.786	-60 %
18	18 Vident Investment Advisory Alpharetta, Georgia	744.000 $	+397.781 $	+42.208	+88 %
19	19 Geode Capital Management Boston, Massachusetts	726.000 $	+28.254 $	+2.998	+4 %
20	20 Northern Trust Chicago, Illinois	604.000 $	+1.301 $	+138	+0,2 %
21	21 ProShare Advisors Bethesda, Maryland	501.000 $	-50.477 $	-5.356	-8 %
22	22 Bank of New York Mellon New York	463.000 $	+141.035 $	+14.965	+36 %
23	23 Swiss National Bank Zurich, Switzerland	289.000 $	+60.787 $	+6.450	+22 %
24	24 DekaBank Deutsche Girozentrale Frankfurt, Germany	287.000 $	+328.908 $	+34.900	Neu
25	25 Millennium Management New York	195.000 $	+223.215 $	+23.685	Neu

ImmunityBio IBRX Börsenwert 8,58 Mrd. $

ImmunityBio

IBRX

Börsenwert 8,58 Mrd. $